Abstract
Accurate identification and delineation of oral precancerous and cancerous lesions is necessary for successful treatment.1, 2, 3, 4 Multispectral widefield imaging is emerging as an attractive, noninvasive means to inspect at-risk oral mucosa. For example, direct autofluorescence visualization has been shown to reveal biochemical changes associated with oral precancer and cancer.5, 6, 7, 8, 9, 10, 11, 12, 13 Reflectance imaging, including narrowband illumination imaging and polarized imaging, has been shown to aid in visualizing vasculature in the oral cavity,14, 15 which increases during malignant progression.16 To optimize outcomes, it is important to identify the imaging modalities, illumination and collection conditions, and/or combinations of modalities that provide the most useful diagnostic information. This information is valuable for optimizing multispectral devices based on direct visualization of the tissue, as well as those based on computer-aided analysis of multispectral digital images.
Funding Information
  • National Institutes of Health (R21DE16485)
  • National Institutes of Health (R01CA124319)
  • NIH (R01CA124319)
  • National Institutes of Health (P50CA097007)

This publication has 28 references indexed in Scilit: